I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Al-Sawaf, Othman
113
results:
Search for persons
X
Format
Online (113)
Mediatypes
E-Books (1)
Articles (Online) (70)
Bookchapter (Online) (1)
OpenAccess-fulltext (41)
Languages
german (4)
english (100)
Sorted by: Relevance
Sorted by: Year
?
1
High-risk stays high-risk: Bruton tyrosine kinase inhibitor..:
Al-Sawaf, Othman
Haematologica. , 2024
Link:
https://doi.org/10.3324/..
?
2
Chronic Lymphocytic Leukemia: Time-Limited Therapy in the F..:
Stumpf, Janina
;
Al-Sawaf, Othman
Current Oncology Reports. 26 (2024) 2 - p. 136-146 , 2024
Link:
https://doi.org/10.1007/..
?
3
P623: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF PIRTO..:
Al-Sawaf, Othman
;
Jen, Min-Hua
;
Hess, Lisa
...
HemaSphere. 7 (2023) S3 - p. e26114b3 , 2023
Link:
https://doi.org/10.1097/..
?
4
Body composition and lung cancer-associated cachexia in TRA..:
Al-Sawaf, Othman
;
Weiss, Jakob
;
Skrzypski, Marcin
...
Nature Medicine. 29 (2023) 4 - p. 846-858 , 2023
Link:
https://doi.org/10.1038/..
?
5
S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATI..:
Langerbeins, Petra
;
Robrecht, Sandra
;
Nieper, Pascal
...
HemaSphere. 7 (2023) S3 - p. e9488123 , 2023
Link:
https://doi.org/10.1097/..
?
6
Tislelizumab plus zanubrutinib for Richter transformation: ..:
Al-Sawaf, Othman
;
Ligtvoet, Rudy
;
Robrecht, Sandra
...
Nature Medicine. 30 (2023) 1 - p. 240-248 , 2023
Link:
https://doi.org/10.1038/..
?
7
Pirtobrutinib versus venetoclax in covalent Bruton tyrosine..:
Al-Sawaf, Othman
;
Jen, Min-Hua
;
Hess, Lisa M
...
Haematologica. , 2023
Link:
https://doi.org/10.3324/..
?
8
Importance of Minimal Residual Disease in the Era of Target..:
Al-Sawaf, Othman
Acta Haematologica. 147 (2023) 1 - p. 22-32 , 2023
Link:
https://doi.org/10.1159/..
?
9
Author Correction: Transcriptomic profiles and 5-year resul..:
Al-Sawaf, Othman
;
Zhang, Can
;
Jin, Hyun Yong
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
10
EXABS-208-CLL MRD+ at 1 Year of VenG: Stop Therapy:
Al-Sawaf, Othman
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S96-S97 , 2023
Link:
https://doi.org/10.1016/..
?
11
S145: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRO..:
Al-Sawaf, Othman
;
Robrecht, Sandra
;
Zhang, Can
...
HemaSphere. 7 (2023) S3 - p. e064430a , 2023
Link:
https://doi.org/10.1097/..
?
12
P622: GENETIC MARKERS AND OUTCOME OF CLL PATIENTS IN COMBIN..:
Yosifov, Deyan
;
von Tresckow, Julia
;
Giza, Adam
...
HemaSphere. 7 (2023) S3 - p. e14818fb , 2023
Link:
https://doi.org/10.1097/..
?
13
Transcriptomic profiles and 5-year results from the randomi..:
Al-Sawaf, Othman
;
Zhang, Can
;
Jin, Hyun Yong
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
14
Pharmacokinetics and Exposure-Response Analysis of Venetocl..:
Samineni, Divya
;
Gibiansky, Leonid
;
Wang, Bei
...
Advances in Therapy. 39 (2022) 8 - p. 3635-3653 , 2022
Link:
https://doi.org/10.1007/..
?
15
Utility of measurable residual disease for predicting treat..:
Wierda, William G.
;
Kipps, Thomas J.
;
Al-Sawaf, Othman
...
Leukemia & Lymphoma. 63 (2022) 12 - p. 2765-2784 , 2022
Link:
https://doi.org/10.1080/..
1-15